Fortress Biotech
FBIO
$1.81
Share price
0.54%
Change (1 day)
138.13%
Change (1 year)
Categories
Operating Margin for Fortress Biotech (FBIO)
Operating Margin as of May 2024 (TTM): -281.82%
According to Fortress Biotech 's latest financial reports and stock price the company's current Operating Margin is -281.82%. At the end of 2021 the company had an Operating Margin of -238.92%.
Operating Margin history for Fortress Biotech from 2016 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -238.92% | 5.93% |
| 2020 | -225.55% | -18.73% |
| 2019 | -277.54% | -42.96% |
| 2018 | -486.57% | 828.3% |
| 2017 | -52.42% | -87.88% |
| 2016 | -432.58% | -93.07% |
| 2015 | -6,243.68% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | -11.67% | -95.86% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -61.01% | -78.35% | 🇺🇸 USA |
 Advaxis ADXS | -549.75% | 95.07% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | 17.64% | -106.26% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.